Abstract
Cerebral ischemia triggers interleukin-6 (IL-6) release into blood. IL-6 is a key mediator of acute phase reaction. Markers of acute phase reaction (C-reactive protein, fibrinogen, fever) have been linked to poor prognosis in stroke patients. Interleukin-6 soluble receptor (sIL-6R) can potentiate IL-6 pro-inflammatory activity. The aim of this study was to investigate the relationship between IL-6 and sIL-6R in stroke patients. Serum cytokine levels were measured in 18 stroke patients and 13 controls using the ELISA method. On the second day of stroke, IL-6 levels were significantly higher in stroke patients than in controls; sIL-6R levels did not differ significantly between groups. Three months after stroke, IL-6 levels did not differ significantly between groups; sIL-6R levels were significantly decreased in stroke patients when compared with that in controls and with levels in acute phase of stroke. Decreased sIL-6R early after stroke might reflect a regulatory mechanism attenuating inflammatory response.
Similar content being viewed by others
References
Acalovschi D., Wiest T., Hartmann M., Farahmi M., Mansmann U., Auffarth G.U., et al. (2003) Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 34, 1864–1869.
Adams H. P., Bendixen B. H., Kappelle L. J., and the TOAST Investigators. (1993) Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 24, 35–41.
Akira S., Taga T., and Kishimoto T. (1993) Interleukin-6 in biology and medicine. Adv. Immunol. 54, 1–78.
Beamer N. B., Coull B. M., Clark W. M., Briley D. P., Wynn D. O., and Sexton G. (1998) Persistent inflammatory response in stroke survivors. Neurology 50, 1722–1728.
Beamer N. B., Coull B. M., Clark W. M., Hazel J. S., and Silberger J. R. (1995) Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann. Neurol. 37, 800–804.
Brott T., Marler J. R., Olinger C. P., Adams H. P., Tomsick T., Barsan W., et al. (1989) Measurements of acute cerebral infarction: lesion size by computed tomography. Stroke 20, 871–875.
DiNapoli M. and Papa F. (2002) Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients. Stroke 33, 1763–1771.
Fassbender K., Rossol S., Kammer T., Daffertshofer M., Wirth S., and Hennerici M. (1994) Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J. Neurol. Sci. 122, 135–139.
Ferrarese C., Mascarucci P., Zoia C., Cavarretta R., Frigo M., Begni B., et al. (1999) Increased cytokine release from peripheral blood cells after acute stroke. J. Cereb. Blood Flow Metab. 19, 1004–1009.
Hans V. H. J., Kossmann T., Joller H., Otto, V., and Morganti-Kossmann M. C. (1999) Interleukin-6 and its soluble receptor in serum and cerebrospinal fluid after cerebral trauma. NeuroReport 10, 409–412.
Heinrich P. C., Behrmann I., Muller-Newen G., Schaper F., and Graeve L. (1998) Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334, 297–314.
Ikonomidis I., Andreotti F., Economou E., Stefanadis C., Toutouzas P., and Nihoyannopoulos P. (1999) Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 100, 793–798.
Johansson A., Ahren B., Nasman B., Carlstrom K., and Olsson T. (2000) Cortisol axis abnormalities early after stroke—relationship to cytokines and leptin. J. Int. Med. 247, 179–187.
Jones S. A., Horiuchi S., Topley N., Yamamoto N., and Fuller G. M. (2001) The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J. 15, 43–58.
Kado S., Nagase T., and Nagata N. (1999) Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus. Acta Diabetol. 36, 67–72.
Kim H. M., Shin H. Y., Jeong H. J., An H. J., Kim N. S., Chae H. J., et al. (2000) Reduced IL-2 but elevated IL-4, IL-6, and IgE serum levels in patients with cerebral infarction during the acute stage. J. Mol Neurosci. 14, 191–196.
Kim J. S., Yoon S. S., Kim Y. H., and Ryu J. S. (1996) Serial measurement of interleukin-6, transforming growth factor-β, and S-100 protein in patients with acute stroke. Stroke 27, 1553–1557.
Lindenstrom E., Boysen G., Christiansen L. W., a Rogvi Hansen B., and Nielsen B. W. (1991) Reliability of Scandinavian Stroke Scale. Cerebrovasc. Dis. 1, 103–107.
Mackiewicz A., Schooltink H., Heinrich P. C., and Rose-John S. (1992) Complex of soluble human IL-6receptor/IL-6 up-regulates expression of acute-phase proteins. J. Immunol. 149, 2021–2027.
Mahoney F. I. and Barthel D. W. (1965) Functional evaluation: the Barthel Index. Md. State Med. J. 15, 61–65.
Neveu P. J., Delrue C., Deleplanque B., D’Amato F. R., Puglisi-Allegra S., and Cabib S. (1994) Influence of brain and behavioral lateralization in brain. Ann. N.Y. Acad. Sci. 64, 271–282.
Perini V. F., Morra M., Alecci M., Galloni E., Marchi M., and Toso V. (2001) Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients. Neurol. Sci. 22, 289–296.
Rogers S. L., Coe C. L., and Karaszewski J. (1998) Immune consequences of stroke and cerebral palsy in adults. J. Neuroimmunol. 91, 113–120.
Romano M., Sironi M., Toniatti C., Polentarutti N., Fruscella P., Ghezzi P., et al. (1997) Role of IL-6 and its soluble receptor in induction of chemokines and lekocyte recruitment. Immunity 6, 315–325.
Tarkowski E., Rosengren L., Blomstrand C., Wikkelso C., Jensen C., Ekholm S., and Tarkowski A. (1995) Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 26, 1393–1398.
Thibault V., Terlain B., and Gauldie J. (1996) Characterization and biologic activities of recombinant rat soluble interleukin-6 receptor. J. Interferon Cytokine Res. 16, 973–981.
Ueda K., Takahashi M., Ozawa K., and Kinoshita M. (1999) Decreased soluble interleukin-6 receptor in patients with acute myocardial infarction. Am. Heart. J. 138, 908–915.
van Swieten J. C., Koudstaal P. J., Visser M. C., Schouten H. J. A., and van Gijn J. (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 23, 89–97.
Vila N., Castillo J., Davalos A., and Chamorro A. (2000) Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 31, 2325–2329.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dziedzic, T., Gryz, E.A., Turaj, W. et al. Serum interleukin-6 soluble receptor in relation to interleukin-6 in stroke patients. J Mol Neurosci 24, 293–298 (2004). https://doi.org/10.1385/JMN:24:2:293
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:24:2:293